1. Chelation of intracellular iron enhances endothelial barrier function: a role for vitamin C?
- Author
-
May JM and Qu ZC
- Subjects
- 2,2'-Dipyridyl pharmacology, Capillary Permeability drug effects, Capillary Permeability physiology, Cell Line, Colchicine pharmacology, Collagen biosynthesis, Cytochalasin B pharmacology, Cytoskeleton drug effects, Cytoskeleton metabolism, Deferoxamine pharmacology, Fluorescent Dyes, Glutathione metabolism, Humans, Hydroxybenzoates pharmacology, Inulin metabolism, Organic Chemicals, Oxyquinoline pharmacology, Ascorbic Acid metabolism, Endothelial Cells drug effects, Endothelial Cells physiology, Iron metabolism, Iron Chelating Agents pharmacology
- Abstract
Ascorbic acid improves endothelial barrier function by decreasing the permeability of endothelial cells cultured on semi-porous membrane filters. This decrease was not due to enhanced collagen synthesis and was mimicked by the collagen synthesis inhibitor ethyl-3,4-dihydroxybenzoic acid (EDHB). Since EDHB is known to chelate intracellular free iron, the effects of two membrane-permeant iron chelators were tested on endothelial permeability. Both 2,2'-dipyridyl and desferrioxamine decreased trans-endothelial permeability in a concentration-dependent manner. Increasing intracellular iron with a chelate of 8-hydroxyquinoline and ferric iron prevented effects of both EDHB and intracellular ascorbate. That EDHB and ascorbate did in fact chelate intracellular iron was supported by finding that they both decreased the cellular fluorescence quenching of the iron-sensitive dye Phen green SK. These results show that chelation of intracellular iron decreases endothelial barrier permeability and implicate this mechanism in the ability of EDHB and possibly intracellular ascorbate to tighten the endothelial barrier., (2010 Elsevier Inc. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF